Key Drivers of Growth
The global travel vaccines market is projected to reach $18.8 billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030. The market growth is driven by several factors, including the expansion in global travel volumes, heightened awareness of region-specific disease risks, and stricter cross-border health protocols.
- Expansion in global travel volumes
- Heightened awareness of region-specific disease risks
- Stricter cross-border health protocols
Technological and Formulation Advances
The field of vaccinology is undergoing significant innovation, with mRNA platforms, thermostable formulations, and combination vaccines being tailored for travel use. These advances are reducing cold chain dependency, extending shelf life, and simplifying dosage schedules-key benefits for last-minute or remote-area travelers.
Key Traveler Segments and Destinations
Tourists, humanitarian workers, international students, and business travelers to high-risk regions are primary consumers of travel vaccines. The surge in eco-tourism, rural tourism, and adventure travel increases exposure to vector-borne diseases and zoonoses, driving vaccination needs.
- Tourists
- Humanitarian workers
- International students
- Business travelers to high-risk regions
Market Segments
The market is segmented by disease type, end-use, and key attributes. The disease type segment includes influenza vaccines, diphtheria vaccines, hepatitis vaccines, and typhoid & other vaccines. The end-use segment includes adult end-use and pediatric end-use. The key attributes segment includes report attribute details, such as the number of pages, forecast period, estimated market value, and compound annual growth rate.
| Segment | Disease Type | End-Use | Key Attributes | |
| Disease Type | Influenza Vaccines | Diphtheria Vaccines | Hepatitis Vaccines | Typhoid & Other Vaccines |
| End-Use | Adult End-Use | Pediatric End-Use | ||
| Key Attributes | Report Attribute Details |
Competitive Market Presence
The report covers key competitors, including Abbott Laboratories, ALK-Abello A/S, AstraZeneca PLC, Bavarian Nordic A/S, and CSL Limited. The competitive market presence is classified as strong, active, niche, or trivial for players worldwide in 2025.
- Abbott Laboratories
- ALK-Abello A/S
- AstraZeneca PLC
- Bavarian Nordic A/S
- CSL Limited
Regional Analysis
The report provides an in-depth regional analysis, including the U.S. market, China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. The U.S. market is estimated at $3.6 billion in 2024 and is forecasted to grow at an impressive 9.4% CAGR to reach $3.8 billion by 2030.
- U.S. Market
- China
- Japan
- Canada
- Europe
- Asia-Pacific
- Latin America
- Middle East
- Africa
Report Features
The report includes comprehensive market data, in-depth regional analysis, company profiles, and complimentary updates. The report attribute details include the number of pages, forecast period, estimated market value, and compound annual growth rate.
- Comprehensive Market Data
- In-Depth Regional Analysis
- Company Profiles
- Complimentary Updates
Scope Of Study
The scope of study includes disease type, end-use, and key attributes. The report attribute details include the number of pages, forecast period, estimated market value, and compound annual growth rate.
- Disease Type
- End-Use
- Key Attributes
Key Topics Covered
The report covers market overview, influencer market insights, world market trajectories, tariff impact on global supply chain patterns, travel vaccines – global key competitors percentage market share in 2025, competitive market presence, market trends & drivers, and growth in business, educational, and medical tourism.
- Market Overview
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Travel Vaccines – Global Key Competitors Percentage Market Share in 2025
- Competitive Market Presence
- Market Trends & Drivers
Focusing on Select Players
The report features 44 companies, including Abbott Laboratories, ALK-Abello A/S, AstraZeneca PLC, Bavarian Nordic A/S, and CSL Limited. The report attribute details include the number of pages, forecast period, estimated market value, and compound annual growth rate.
- Abbott Laboratories
- ALK-Abello A/S
- AstraZeneca PLC
- Bavarian Nordic A/S
- CSL Limited
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. The report provides comprehensive market data, in-depth regional analysis, company profiles, and complimentary updates.
“The global travel vaccines market is expected to reach $18.8 billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030.
